Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders

Haematologica

Volumn 89, Issue 2, 2004, Pages 245-246

  Garypidou, Vasilia ^a   Vakalopoulou, Sofia ^a   Dimitriadis, Dimokritos ^a   Tziomalos, Konstantinos ^a,b   Sfikas, George ^a   Perifanis, Vasilios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Myeloproliferative disorders; Pulmonary hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; CLOPIDOGREL; DANAZOL; DIPYRIDAMOLE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; INTERFERON; PREDNISOLONE; THALIDOMIDE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE PRESSURE; HUMAN; INCIDENCE; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PULMONARY HYPERTENSION; THROMBOCYTHEMIA; COHORT ANALYSIS; ECHOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PROSPECTIVE STUDIES;

EID: 2942573587     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-65.
2. Tefferi A, Silverstein MN, Hoagland HC. Primary thrombocythemia. Semin Oncol 1995;22:334-40.
3. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc 2003;78:174-94.
4. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001;120:801-8.
5. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative disorders. Am J Hematol 1999;60:130-5.
6. Reisner SA, Rinkevich D, Markiewicz W, Tatarsky I, Brenner B. Cardiac involvement in patients with myeloproliferative disorders. Am J Med 1992;93:498-504.
7. Marvin KS, Spellberg RD. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest 1993;103:642-4.
8. Martin-Duran R, Larman M, Trugeda A, Vazquez de Prada JA, Ruano J, Torres A, et al. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol 1986;57:859-63.
9. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336:111-7.
10. Steensma DP, Hook CC, Stafford SL, Tefferi A. Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia. Br J Haematol 2002;118:813-6.